BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23764537)

  • 1. Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine.
    Launay O; Paul S; Servettaz A; Roguet G; Rozenberg F; Lucht F; Lambert C; Presles E; Goulvestre C; Méritet JF; Galtier F; Dubray C; Lebon P; Weill B; Batteux F
    Vaccine; 2013 Aug; 31(35):3492-501. PubMed ID: 23764537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Campos LM; Silva CA; Aikawa NE; Jesus AA; Moraes JC; Miraglia J; Ishida MA; Bueno C; Pereira RM; Bonfa E
    Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
    Del Porto F; Laganà B; Biselli R; Donatelli I; Campitelli L; Nisini R; Cardelli P; Rossi F; D'Amelio R
    Vaccine; 2006 Apr; 24(16):3217-23. PubMed ID: 16466833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.
    Mathian A; Devilliers H; Krivine A; Costedoat-Chalumeau N; Haroche J; Huong DB; Wechsler B; Hervier B; Miyara M; Morel N; Le Corre N; Arnaud L; Piette JC; Musset L; Autran B; Rozenberg F; Amoura Z
    Arthritis Rheum; 2011 Nov; 63(11):3502-11. PubMed ID: 21811996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccination in systemic lupus erythematosus: safe and protective?
    Holvast B; Huckriede A; Kallenberg CG; Bijl M
    Autoimmun Rev; 2007 Apr; 6(5):300-5. PubMed ID: 17412302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
    Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM
    Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Holvast A; Huckriede A; Wilschut J; Horst G; De Vries JJ; Benne CA; Kallenberg CG; Bijl M
    Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
    Wallin L; Quintilio W; Locatelli F; Cassel A; Silva MB; Skare TL
    Acta Reumatol Port; 2009; 34(3):498-502. PubMed ID: 19820674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus.
    Wang A; Guilpain P; Chong BF; Chouzenoux S; Guillevin L; Du Y; Zhou XJ; Lin F; Fairhurst AM; Boudreaux C; Roux C; Wakeland EK; Davis LS; Batteux F; Mohan C
    Arthritis Rheum; 2010 Nov; 62(11):3436-46. PubMed ID: 20722038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
    Urowitz MB; Anton A; Ibanez D; Gladman DD
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus.
    Chong BF; Mohan C
    Expert Opin Ther Targets; 2009 Oct; 13(10):1147-53. PubMed ID: 19670960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
    Cullen G; Bader C; Korzenik JR; Sands BE
    Gut; 2012 Mar; 61(3):385-91. PubMed ID: 21757451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination of patients with systemic lupus erythematosus.
    Mercado U; Acosta H; Avendaño L
    Rev Invest Clin; 2004; 56(1):16-20. PubMed ID: 15144037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?
    Borba EF; Saad CG; Pasoto SG; Calich AL; Aikawa NE; Ribeiro AC; Moraes JC; Leon EP; Costa LP; Guedes LK; Silva CA; Goncalves CR; Fuller R; Oliveira SA; Ishida MA; Precioso AR; Bonfa E
    Rheumatology (Oxford); 2012 Jun; 51(6):1061-9. PubMed ID: 22298793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.
    Le Corre N; Thibault F; Pouteil Noble C; Meiffrédy V; Daoud S; Cahen R; Charreau I; Bottigioli D; Dollinger C; Aboulker JP; Autran B; Morelon E; Barrou B
    Vaccine; 2012 Dec; 30(52):7522-8. PubMed ID: 23103195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
    Stojanovich L
    Clin Dev Immunol; 2006; 13(2-4):373-5. PubMed ID: 17162380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific antibody response after influenza immunization in systemic lupus erythematosus.
    Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
    J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy.
    Bálint A; Farkas K; Éva PK; Terhes G; Urbán E; Szucs M; Nyári T; Bata Z; Nagy F; Szepes Z; Miheller P; Lorinczy K; Lakatos PL; Lovász B; Tamás S; Kulcsár A; Berényi A; Törocsik D; Daróczi T; Saródi Z; Wittmann T; Molnár T
    Scand J Gastroenterol; 2015 Feb; 50(2):174-81. PubMed ID: 25384624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.